Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for screening antidiabetic active compounds

An anti-diabetic, compound technology, applied in the field of drug screening, achieves the effects of good reproducibility, optimized conditions, and reduced preparation and separation steps

Active Publication Date: 2012-12-19
ZHEJIANG WANBANG PHARMA
View PDF10 Cites 14 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The invention provides a method for screening antidiabetic active compounds, which overcomes the problem in the prior art that only single target or enzyme active compounds can be screened

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for screening antidiabetic active compounds
  • Method for screening antidiabetic active compounds
  • Method for screening antidiabetic active compounds

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0032] The present invention will be further explained below in conjunction with the accompanying drawings and embodiments, which are only used to illustrate the present invention rather than limit the present invention.

[0033] Instruments used in the examples: AgiLent 100 type liquid chromatography (AgiLent Company); Finnigan LCQ Deca XPpLus liquid chromatography-mass spectrometry instrument (Finnigan Company).

[0034]1. Active compound screening system based on multiple enzyme magnetic beads

[0035] 1. Reagent and solution preparation:

[0036] Maltase, sucrase, porcine pancreatic lipase (Simga); carboxyl magnetic beads Dynabeads® MyOne CarboxyLic Acid, specification: 10mg / mL (invitrogen); 1-ethyl-3-(3-dimethylaminopropyl) Carbodiimide hydrochloride (EDC, sigma company); 2-(N-morpholine) ethanesulfonic acid (MES, sigma company); N-hydroxysuccinimide (NHS, sigma company).

[0037] Preparation of 25mmol / L MES aqueous solution: Weigh an appropriate amount of MES, add wate...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Ionic strengthaaaaaaaaaa
Login to View More

Abstract

The invention discloses a method for screening antidiabetic active compounds. The method is characterized by comprising the steps of: (1) preparing bonding enzyme magnetic beads; (2) using at least two kinds of the bonding enzyme magnetic beads to conduct preferential adsorption on a traditional Chinese medicine solution or a natural extractive solution, enabling target proteins bonded on different bonding enzyme magnetic beads to be mutually different, and enabling the target proteins to be maltase, sucrase or lipase; (3) separating compounds jointly absorbed by all bonding enzyme magnetic beads to serve as a sample set; and (4) screening the antidiabetic active compounds from the sample set through inhibitory activity tests directing at the target proteins. The method for screening antidiabetic active compounds can screen the antidiabetic active compounds in a traditional Chinese medicine or a natural extractive aiming at multiple target points or enzymes, is applicable to development of anti-diabetic medicines, simultaneously reduces compound preparation and separation steps during initial screening in a traditional method, improves screening efficiency and shortens screening times.

Description

technical field [0001] The invention relates to the field of drug screening, in particular to a method for screening antidiabetic active compounds. Background technique [0002] Diabetes is a chronic metabolic disorder. If diabetes is not well controlled, it will lead to various complications, which can damage multiple tissues and organs in the human body, resulting in disability and high mortality. Diabetes has become a global epidemic. According to the report of WHO, there are about 160 million diabetic patients in the world. The total number of diabetics in my country has reached more than 40 million, second only to India, ranking second in the world, and the harm is huge. [0003] At present, the main intervention strategies for the treatment of diabetes are diet control, reducing the content of ingested carbohydrates, etc. Type I diabetes can only rely on insulin-dependent treatment because the cells of the pancreas that produce insulin have been completely damaged. T...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G01N33/15
Inventor 程翼宇王毅
Owner ZHEJIANG WANBANG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com